Safety and Immunogenicity of a Protein Subunit COVID-19 Vaccine (ZF2001) in Healthy Children and Adolescents Aged 3–17 Years in China: a Randomised, Double-Blind, Placebo-Controlled, Phase 1 Trial and an Open-Label, Non-Randomised, Non-Inferiority, Phase 2 Trial
The Lancet Child & Adolescent Health(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要